CollPlant Biotechnologies Statistics
Total Valuation
CLGN has a market cap or net worth of $25.20 million. The enterprise value is $16.37 million.
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025, before market open.
Earnings Date | May 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CLGN has 11.45 million shares outstanding. The number of shares has increased by 0.57% in one year.
Current Share Class | 11.45M |
Shares Outstanding | 11.45M |
Shares Change (YoY) | +0.57% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 32.27% |
Owned by Institutions (%) | 11.18% |
Float | 7.65M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 49.15 |
Forward PS | 2.74 |
PB Ratio | 1.88 |
P/TBV Ratio | 1.89 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 31.79 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.44, with a Debt / Equity ratio of 0.23.
Current Ratio | 4.44 |
Quick Ratio | 4.21 |
Debt / Equity | 0.23 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -79.46% and return on invested capital (ROIC) is -44.88%.
Return on Equity (ROE) | -79.46% |
Return on Assets (ROA) | -40.81% |
Return on Invested Capital (ROIC) | -44.88% |
Return on Capital Employed (ROCE) | -109.60% |
Revenue Per Employee | $9,035 |
Profits Per Employee | -$291,386 |
Employee Count | 57 |
Asset Turnover | 0.02 |
Inventory Turnover | 2.82 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.65% in the last 52 weeks. The beta is 0.74, so CLGN's price volatility has been lower than the market average.
Beta (5Y) | 0.74 |
52-Week Price Change | -62.65% |
50-Day Moving Average | 2.85 |
200-Day Moving Average | 3.96 |
Relative Strength Index (RSI) | 33.33 |
Average Volume (20 Days) | 12,959 |
Short Selling Information
Short Interest | 2,319 |
Short Previous Month | 1,876 |
Short % of Shares Out | 0.03% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.17 |
Income Statement
In the last 12 months, CLGN had revenue of $515,000 and -$16.61 million in losses. Loss per share was -$1.45.
Revenue | 515,000 |
Gross Profit | -1.11M |
Operating Income | -17.25M |
Pretax Income | -7.50M |
Net Income | -16.61M |
EBITDA | -16.21M |
EBIT | -17.25M |
Loss Per Share | -$1.45 |
Full Income Statement Balance Sheet
The company has $11.91 million in cash and $3.08 million in debt, giving a net cash position of $8.83 million or $0.77 per share.
Cash & Cash Equivalents | 11.91M |
Total Debt | 3.08M |
Net Cash | 8.83M |
Net Cash Per Share | $0.77 |
Equity (Book Value) | 13.47M |
Book Value Per Share | 1.18 |
Working Capital | 10.21M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$14.09 million and capital expenditures -$483,000, giving a free cash flow of -$14.58 million.
Operating Cash Flow | -14.09M |
Capital Expenditures | -483,000 |
Free Cash Flow | -14.58M |
FCF Per Share | -$1.27 |
Full Cash Flow Statement Margins
Gross Margin | -215.53% |
Operating Margin | -3,349.71% |
Pretax Margin | -3,225.05% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CLGN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.57% |
Shareholder Yield | -0.57% |
Earnings Yield | -65.91% |
FCF Yield | -57.84% |
Analyst Forecast
The average price target for CLGN is $12.50, which is 468.18% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.50 |
Price Target Difference | 468.18% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.6666666:1.
Last Split Date | Nov 21, 2016 |
Split Type | Reverse |
Split Ratio | 0.6666666:1 |
Scores
CLGN has an Altman Z-Score of -4.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.32 |
Piotroski F-Score | 1 |